 |
Chimeric monoclonal antibody to CD30 (anti-CD30 antibody) |
|---|---|
| Trade Name | |
| Orphan Indication | Hodgkin’s disease |
| USA Market Approval | USA |
| USA Designation Date | 2003-07-18 00:00:00 |
| Sponsor | Seattle Genetics, Inc;21823 30th Drive, Southeast;Bothell, Washington, 98021 |
